Interventional cytopathology and cancer in Peru: how to act during COVID-19?
| Autor: | Caddie Laberiano Fernández, Himelda Chávez Torres, Edwin Figueroa, Ricardo Bardales, Milagros Abad-Licham, Grisnery Maquera Torres, Juan C Astigueta |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cancer Research
medicine.medical_specialty business.industry Short Communication Risk of infection COVID-19 biosafety Cancer Context (language use) 030224 pathology medicine.disease 03 medical and health sciences Biosafety 0302 clinical medicine Oncology Cytopathology 030220 oncology & carcinogenesis fine-needle biopsy Health care Pandemic medicine cancer Intensive care medicine business Cancer staging |
| Zdroj: | ecancermedicalscience |
| ISSN: | 1754-6605 |
| DOI: | 10.3332/ecancer.2020.1152 |
| Popis: | The worldwide health crisis due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected all healthcare systems. Low- and middle-income countries have needed to establish health strategies to combat the pandemic, many of which have collaterally affected the diagnosis and treatment of other illnesses. One of these other illnesses is cancer, which in Peru represents the primary cause of mortality. In recent decades, interventional cytopathology with fine-needle biopsy techniques has emerged as a minimally invasive, rapid, economical and effective procedure for diagnosing and staging cancer. However, in the current health context, it is confronted by the challenge of continuing to function in spite of the pandemic. This article reviews the existing literature on interventional cytopathology, the risk of infection from SARS-CoV-2 and biosafety and provides recommendations for carrying out said procedures for the benefit of the patient and the safety of healthcare staff. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|